Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06972667 · ClinicalTrials.gov registry record · NA
Interventions to Decrease Health Information Avoidance
A NA study of Health Information Avoidance, sponsored by State University of New York at Buffalo.
- Active
- Registry status
- NA
- Development phase
- 1,500
- Enrollment target
- 1
- Study location
NCT06972667: Active NA study of Health Information Avoidance, sponsored by State University of New York at Buffalo.
NCT06972667 is a NA study of Health Information Avoidance that is active but no longer recruiting, run by State University of New York at Buffalo. The registered enrollment target is 1,500 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06972667, a NA study of Health Information Avoidance, is active but no longer recruiting, sponsored by State University of New York at Buffalo.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,500 participants
- Enrollment target
- 1
- Study location
Study Summary
Health information avoidance is an overlooked threat to the reach and effectiveness of health communication. To fully realize the benefits of our sizeable investments in health messaging, it is necessary to identify strategies for reducing health information avoidance. The researchers will test a video-based strategy for promoting colorectal cancer screening designed to reduce defensive colorectal cancer information avoidance and increase message reach by increasing engagement among those who would otherwise avoid the message. The researchers will conduct a randomized controlled trial (RCT) comparing the effects of the intervention video to an attentional control video on colorectal cancer screening intentions and uptake.
Primary Outcome
Participants will rate their intention to be screened with the item, "I intend to get checked for colon cancer within the next 6 months" on a scale from 1 to 4 with 4 being stronger intentions.
Conditions Studied
Interventions
- OTHER Video to promote colonoscopy
- OTHER Video to promote screening for colorectal cancer with home tests
Study Locations (1)
New York
- University at Buffalo - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2025-12-10 |
| Est. Completion | 2026-09 |
| Phase | NA |
What the registry record for NCT06972667 still lists
NCT06972667 is an interventional study that assigns participants to a tested intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 1 condition, with Health Information Avoidance appearing as the primary indexed condition, and to 2 interventions - of which Video to promote colonoscopy is the first listed.
NCT06972667 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06972667 about?
NCT06972667 is a clinical study titled "Interventions to Decrease Health Information Avoidance". Health information avoidance is an overlooked threat to the reach and effectiveness of health communication. To fully realize the benefits of our sizeable investments in health messaging, it is necessary to identify strategies for reducing health information avoidance. The researchers will test a vi...
What is the current status of trial NCT06972667?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,500 participants. The study started on 2025-12-10. Estimated completion is 2026-09.
What conditions does trial NCT06972667 study?
This clinical trial studies the following conditions: Health Information Avoidance.
What interventions are being tested in trial NCT06972667?
The interventions under investigation include: Video to promote colonoscopy (OTHER), Video to promote screening for colorectal cancer with home tests (OTHER).
Who is sponsoring clinical trial NCT06972667?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06972667 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06972667's enrollment target sits among peer trials
1,500 65th of 2000 higher than 1,933 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- NCT02071134 · 1,500 participants
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI